Clinical Scorecard: Is Point-of-Care Hepatitis C Virus Testing Too Expensive?

At a Glance

Key Highlights

• Point-of-care RNA testing could increase hospital laboratory costs by up to 260%.
• Emergency department testing increased 682% from 2017 to 2024.
• HCV antigen testing is a cost-effective alternative, adding only $11,494 in annual costs.

Guideline-Based Recommendations

Diagnosis

• Consider point-of-care RNA testing for immediate treatment initiation.

Management

• Evaluate cost implications of point-of-care testing versus traditional methods.

Monitoring & Follow-up

• Track antibody positivity rates in different care settings.

Risks

• Increased laboratory costs may impact other testing services.

Patient & Prescribing Data

Patients diagnosed with HCV in emergency departments.

Immediate treatment initiation is possible with rapid RNA tests.

Clinical Best Practices

• Implement targeted deployment strategies for HCV testing.
• Consider HCV antigen testing as a cost-effective alternative.

References

• Journal of Clinical Microbiology